Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Refine search results

Journals help

  1. 2 Biotechnologia

Years help

  1. 1 2002

  2. 1 2000

Authors help

  1. 1 Anderson B.

  2. 1 Tudek B.

Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  LEGISLATION
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1

Genetically modified microorganisms, their application and activities of European Union and Poland to ensure biosafety

100%
Tudek B.
Biotechnologia
|
2002
|
issue 4
239-260
EN
Genetically modified microorganisms (GMM) are widely applied in research, medicine, pharmaceutical and food industries, as well as in agriculture and environment protection. The assessment of actual risk to human health and to environment related to GMM application is often difficult, because these is unsufficient experience in the application of GMM in areas other than research. That is why European Union, as well as Poland, have undertaken several activities serving to prevent any harm to human health and/or to environment, which might result from utilization of genetic engineering. These activities are performed on the level of legislation and on the level of research programs, aiming at the establishment of effective methods of GMM containment and control. Polish law on Genetically Modified Organisms from 22 June 2001 builds the safety system in Poland in accordance with EU Directives. Additional legislative documents, supporting such system are European Standards which describe in detail particular issues connected to biosafety in laboratories, industry and environment. European standards are adopted to Polish standardization by Polish Committee for Standardization.
2

Market access issues for transgenic plants in Canada and abroad

100%
Anderson B.
Biotechnologia
|
2000
|
issue 2
34-40
EN
In this paper the factors affecting the commercialization of ag-biotech products in Canada destined for international markets. Public acceptance issues, lack of internationally harmonized regulatory systems and data requirements, politicized regulatory systems, intellectual property rights, unclear and inconsistent labeling laws, and the current uncertainty cultivated by the United Nations Convention on Biological Diversity (CBD) Biosafety Protocol, all contribute to market access barriers for Genetically Modified Organisms (GMOs) are discussed.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.